Jiacheng Bi

Loop profile ORCID

Publication Activity (10 Years)

Years Active: 2018-2023
Publications (10 Years): 9

Top Topics

Ulcerative Colitis

Endoplasmic Reticulum Stress

Natural Killer Cells

Cell Cycle Arrest

Top Venues

Cellular & molecular immunology

Science advances

Nature immunology

This page only lists publications with an associated author ORCID identifier.

Publications

Lukman O Afolabi, Jiacheng Bi, Liang Chen, Xiaolu Yang, Xiaochun Wan
Suppression of protein quality control system by TRIM30a sensitises tumour cells to NK cell-mediated immune surveillance. Immunology (2023)
Jiacheng Bi
NK cell dysfunction in patients with COVID-19. Cellular & molecular immunology 19 (2) (2022)
Xiaohu Zheng, Yaqi Wu, Jiacheng Bi, Yingying Huang, Ying Cheng, Yangyang Li, Yuwei Wu, Guoshuai Cao, Zhigang Tian
The use of supercytokines, immunocytokines, engager cytokines, and other synthetic cytokines in immunotherapy. Cellular & molecular immunology 19 (2) (2022)
Jiacheng Bi, Chaoyue Zheng, Xiaohu Zheng
Increased expression of adenosine A3 receptor in tumor-infiltrating natural killer cells. Cellular & molecular immunology 18 (2) (2021)
Jiacheng Bi, Chen Cheng, Chaoyue Zheng, Chen Huang, Xiaohu Zheng, Xianchun Wan, Youhai H Chen, Zhigang Tian, Haoyu Sun
TIPE2 is a checkpoint of natural killer cell maturation and antitumor immunity. Science advances 7 (38) (2021)
Jiacheng Bi
CD226: a potent driver of antitumor immunity that needs to be maintained. Cellular & molecular immunology (2021)
Chaoyue Zheng, Haisi Wu, Zhen Lu, Jiacheng Bi, Xiaochun Wan
IL-33-induced reactive oxygen species are required for optimal metabolic programming in group 2 innate lymphoid cells. Cellular & molecular immunology 17 (12) (2020)
Lukman O Afolabi, Adeleye O Adeshakin, Musbahu M Sani, Jiacheng Bi, Xiaochun Wan
Genetic reprogramming for NK cell cancer immunotherapy with CRISPR/Cas9. Immunology 158 (2) (2019)
Qing Zhang, Jiacheng Bi, Xiaodong Zheng, Yongyan Chen, Hua Wang, Wenyong Wu, Zhengguang Wang, Qiang Wu, Hui Peng, Haiming Wei, Rui Sun, Zhigang Tian
Blockade of the checkpoint receptor TIGIT prevents NK cell exhaustion and elicits potent anti-tumor immunity. Nature immunology 19 (7) (2018)